Mitochondrial chaperone trap1 and the calcium binding protein sorcin interact and protect cells against apoptosis induced by antiblastic agents

Cancer Research

Volumn 70, Issue 16, 2010, Pages 6577-6586

  Landriscina, Matteo ^a   Laudiero, Gabriella ^c   Maddalena, Francesca ^a   Amoroso, Maria Rosaria ^c   Piscazzi, Annamaria ^a   Cozzolino, Flora ^c,d   Monti, Maria ^c,d   Garbi, Corrado ^c   Fersini, Alberto ^b   Pucci, Piero ^c,d   Esposito, Franca ^c,d  

^a Clinical Oncology Unit   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; FLUOROURACIL; IRINOTECAN; MESSENGER RNA; OXALIPLATIN; PROTEIN TRAP1; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; SORCIN; UNCLASSIFIED DRUG; CALCIUM; CALCIUM BINDING PROTEIN; HEAT SHOCK PROTEIN 90; SRI PROTEIN, HUMAN; TRAP1 PROTEIN, HUMAN;

AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL PROTECTION; COLORECTAL CARCINOMA; CONTROLLED STUDY; DOWN REGULATION; ELECTROPHORETIC MOBILITY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; HUMAN; HUMAN CELL; MITOCHONDRION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; WESTERN BLOTTING; BONE TUMOR; COLON TUMOR; DRUG RESISTANCE; ENZYME SPECIFICITY; HCT116 CELL LINE; METABOLISM; OSTEOSARCOMA; PATHOLOGY; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; TUMOR CELL LINE;

APOPTOSIS; BONE NEOPLASMS; CALCIUM; CALCIUM-BINDING PROTEINS; CELL LINE, TUMOR; COLONIC NEOPLASMS; DRUG RESISTANCE, NEOPLASM; HCT116 CELLS; HSP90 HEAT-SHOCK PROTEINS; HUMANS; MITOCHONDRIA; OSTEOSARCOMA; PROTEIN STRUCTURE, TERTIARY; SUBSTRATE SPECIFICITY;

EID: 77955762940     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-10-1256     Document Type: Article

References (34)

1. Hwang M, Moretti L, Lu B. HSP90 inhibitors: multitarget antitumor effects and novel combinatorial therapeutic approaches in cancer therapy. Curr Med Chem 2009;16:3081-92.
2. Montesano Gesualdi N, Chirico G, Catanese MT, Pirozzi G, Esposito F. AROS-29 is involved in adaptive response to oxidative stress. Free Radic Res 2006;40:467-76.
3. Costantino E, Maddalena F, Calise S, et al. TRAP1, a novel mitochondrial chaperone responsible for multi-drug resistance and protection from apoptosis in human colorectal carcinoma cells. Cancer Lett 2009;279:39-46.
4. Leav I, Plescia J, Goel HL, et al. Cytoprotective mitochondrial chaperone TRAP-1 As a novel molecular target in localized and metastatic prostate cancer. Am J Pathol 2009;176:393-401.
5. Fang W, Li X, Jiang Q, Liu Z, Yang H, Wang S. Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China. Transl Med 2008;6:32.
6. Xu L, Voloboueva LA, Ouyang Y, Emery JF, Giffard RG. Overexpression of mitochondrial Hsp70/Hsp75 in rat brain protects mitochondria, reduces oxidative stress, and protects from focal ischemia. J Cereb Blood Flow Metab 2009;29:365-74.
7. Kang BH, Plescia J, Dohi T, Rosa J, Doxsey SJ, Altieri DC. Regulation of tumor cell mitochondrial homeostasis by an organelle-specific Hsp90 chaperone network. Cell 2007;131:257-70.
8. Kubota K, Inoue K, Hashimoto R, et al. Tumor necrosis factor receptor-associated protein 1 regulates cell adhesion and synaptic morphology via modulation of N-cadherin expression. J Neurochem 2009;110:496-508.
9. Meyers MB, Pickel VM, Sheu SS, Sharma VK, Scotto KW, Fishman GI. Association of Sorcin with the cardiac ryanodine receptor. J Biol Chem 1995;270:26411-18.
10. Verzili D, Zamparelli C, Mattei B, Noegel AA, Chiancone E. The Sorcin annexin VII calcium- dependent interaction requires the Sorcin N-terminal domain. FEBS Lett 2000;471:197-200.
11. Meyers MB, Puri TS, Chien AJ, et al. Sorcin associates with the poreforming subunit of voltage dependent L-type Ca2+ channels. J Biol Chem 1998;273:18930-35.
12. Zamparelli C, Macquaide N, Colotti G, et al. Activation of the cardiac Na(+)-Ca(2+) exchanger by sorcin via the interaction of the respective Ca(2+)-binding domains. J Mol Cell Cardiol 2010;49:132-41.
13. Giai M, Biglia N, Sismondi P. Chemoresistance in breast tumors. Eur J Gynaecol Oncol 1991;12:359-73.
14. Padar S, van Breemen C, Thomas DW, Uchizono JA, Livesey JC, Rahimian R. Differential regulation of calcium homeostasis in adenocarcinoma cell line A549 and its Taxol-resistant subclone. Br J Pharmacol 2004;142:305-16.
15. Kawakami M, Nakamura T, Okamura N, et al. Knock-down of Sorcin induces up-regulation of MDR1 in HeLa cells. Biol Pharm Bull 2007;30:1065-73.
16. He QC, Zhang GY, Cao WJ. Correlation of Sorcin overexpression to multidrug resistance of human gastric cancer cell line SGC7901. Ai Zheng 2008;27:337-42.
17. Deng L, Su T, Leng A, et al. Upregulation of soluble resistance-related calcium-binding protein (Sorcin) in gastric cancer. Med Oncol 2009.
18. Yang YX, Chen ZC, Zhang GY, Yi H, Xiao ZQ. A subcellular proteomic investigation into vincristine-resistant gastric cancer cell line. J Cell Biochem 2008;104:1010-21.
19. Qu Y, Yang Y, Liu B, Xiao W. Comparative proteomic profiling identified Sorcin being associated with gemcitabine resistance in nonsmall cell lung cancer. Med Oncol 2009.
20. Nagpal JK, Das BR. Identification of differentially expressed chewing-mediated oral cancer by differential display-polymerase chain reaction. Eur J Clin Invest 2007;37:658-64.
21. Montesano Gesualdi N, Chirico G, Pirozzi G, Costantino E, Landriscina M,Esposito F. Tumor necrosis factor-associated protein 1 (TRAP-1) protects cells from oxidative stress and apoptosis. Stress 2007;10:342-50.
22. Zito E, Buono M, Pepe S, et al. Sulfatase modifying factor 1 trafficking through the cells: from endoplasmic reticulum to the endoplasmic reticulum. EMBO J 2007;26:2443-53.
23. George TC, Basiji DA, Hall BE, et al. Distinguishing modes of cell death using the ImageStream multispectral imaging flow cytometer. Cytometry A 2004;59:237-45.
24. Tang T, Zheng B, Chen SH, et al. hNOA1 interacts with complex I and DAP3 and regulates mitochondrial respiration and apoptosis. J Biol Chem 2009;284:5414-24.
25. Pisa V, CozzolinoM, Gargiulo S, et al. Themolecular chaperone Hsp90 is a component of the cap-binding complex and interacts with the translational repressorCup during Drosophila oogenesis. Gene 2009;432:67-74.
26. Felts SJ, Owen BA, Nguyen P, Trepel J, Donner DB, Toft DO. The hsp90-related protein TRAP1 is a mitochondrial protein with distinct functional properties. J Biol Chem 2000;275:3305-12.
27. Pickel VM, Clarke CL, Meyers MB. Ultrastructural localization of Sorcin, a 22 kDa calcium binding protein, in the rat caudate-putamen nucleus: association with ryanodine receptors and intracellular calcium release. J Comp Neurol 1997;386:625-34.
28. Bernardi P, Rasola A. Calcium and cell death: the mitochondrial connection. Subcell Biochem 2007;45:481-506.
29. Landriscina M, Maddalena F, Laudiero G, Esposito F. Adaptation to oxidative stress, chemoresistance, and cell survival. Antioxid Redox Signal 2009;11:2701-16.
30. Landriscina M, Amoroso MR, Piscazzi A, Esposito F. Heat shock proteins, cell survival and drug resistance. The mitochondrial chaperone TRAP1, a potential novel target for ovarian cancer therapy. Gynecol Oncol 2010;117:177-82.
31. O'Neil BH, Goldberg RM. Chemotherapy for advanced colorectal cancer: Let's not forget how we got here (until we really can). Semin Oncol 2005;32:35-42.
32. Tournigand C, André T, Achille E, et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 2004;22:229-37.
33. Miyata Y. Hsp90 inhibitor geldanamycin and its derivatives as novel cancer chemotherapeutic agents. Curr Pharm Des 2005;11:1131-8.
34. Kang BH, Altieri DC. Compartmentalized cancer drug discovery targeting mitochondrial Hsp90 chaperones. Oncogene 2009;28:3681-8.